Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Revenue

    Back to Income Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹760 Cr₹631 Cr₹513 Cr₹466 Cr₹428 Cr

What is the latest Revenue of WINDLAS BIOTECH ?

The latest Revenue ratio of WINDLAS BIOTECH is ₹760 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹760 Cr
Mar2024₹631 Cr
Mar2023₹513 Cr
Mar2022₹466 Cr
Mar2021₹428 Cr

How is Revenue of WINDLAS BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹760 Cr
20.43
Mar2024 ₹631 Cr
22.97
Mar2023 ₹513 Cr
10.12
Mar2022 ₹466 Cr
8.96
Mar2021 ₹428 Cr -

Compare Revenue of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,670.8 Cr -5.4% 4.8% -17.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-5.4%

4.8%

-17.6%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses